Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Selective activation of estrogen receptor-beta target genes by 3,3'-diindolylmethane.

Vivar OI, Saunier EF, Leitman DC, Firestone GL, Bjeldanes LF.

Endocrinology. 2010 Apr;151(4):1662-7. doi: 10.1210/en.2009-1028. Epub 2010 Feb 16.

2.
3.

Selective activation of estrogen receptor-beta transcriptional pathways by an herbal extract.

Cvoro A, Paruthiyil S, Jones JO, Tzagarakis-Foster C, Clegg NJ, Tatomer D, Medina RT, Tagliaferri M, Schaufele F, Scanlan TS, Diamond MI, Cohen I, Leitman DC.

Endocrinology. 2007 Feb;148(2):538-47. Epub 2006 Nov 9.

PMID:
17095596
4.

Estrogen Receptors alpha and beta as determinants of gene expression: influence of ligand, dose, and chromatin binding.

Chang EC, Charn TH, Park SH, Helferich WG, Komm B, Katzenellenbogen JA, Katzenellenbogen BS.

Mol Endocrinol. 2008 May;22(5):1032-43. doi: 10.1210/me.2007-0356. Epub 2008 Feb 7.

5.

Differential effects of xenoestrogens on coactivator recruitment by estrogen receptor (ER) alpha and ERbeta.

Routledge EJ, White R, Parker MG, Sumpter JP.

J Biol Chem. 2000 Nov 17;275(46):35986-93.

6.
7.

Estrogen receptor beta binds to and regulates three distinct classes of target genes.

Vivar OI, Zhao X, Saunier EF, Griffin C, Mayba OS, Tagliaferri M, Cohen I, Speed TP, Leitman DC.

J Biol Chem. 2010 Jul 16;285(29):22059-66. doi: 10.1074/jbc.M110.114116. Epub 2010 Apr 19.

8.

Indole-3-carbinol selectively uncouples expression and activity of estrogen receptor subtypes in human breast cancer cells.

Sundar SN, Kerekatte V, Equinozio CN, Doan VB, Bjeldanes LF, Firestone GL.

Mol Endocrinol. 2006 Dec;20(12):3070-82. Epub 2006 Aug 10.

PMID:
16901971
9.

Endocrine-Disrupting Chemicals (EDCs): In Vitro Mechanism of Estrogenic Activation and Differential Effects on ER Target Genes.

Li Y, Luh CJ, Burns KA, Arao Y, Jiang Z, Teng CT, Tice RR, Korach KS.

Environ Health Perspect. 2013 Apr;121(4):459-66. doi: 10.1289/ehp.1205951. Epub 2013 Feb 5.

10.

Estrogen receptor beta isoform-specific induction of transforming growth factor beta-inducible early gene-1 in human osteoblast cells: an essential role for the activation function 1 domain.

Hawse JR, Subramaniam M, Monroe DG, Hemmingsen AH, Ingle JN, Khosla S, Oursler MJ, Spelsberg TC.

Mol Endocrinol. 2008 Jul;22(7):1579-95. doi: 10.1210/me.2007-0253. Epub 2008 May 15.

11.

Generation of stable reporter breast cancer cell lines for the identification of ER subtype selective ligands.

Shanle EK, Hawse JR, Xu W.

Biochem Pharmacol. 2011 Dec 15;82(12):1940-9. doi: 10.1016/j.bcp.2011.08.026. Epub 2011 Sep 6.

13.

Stimulatory cross-talk between NFAT3 and estrogen receptor in breast cancer cells.

Zhang H, Xie X, Zhu X, Zhu J, Hao C, Lu Q, Ding L, Liu Y, Zhou L, Liu Y, Huang C, Wen C, Ye Q.

J Biol Chem. 2005 Dec 30;280(52):43188-97. Epub 2005 Oct 11.

14.

Estrogenic properties of naturally occurring prenylated isoflavones in U2OS human osteosarcoma cells: Structure-activity relationships.

Djiogue S, Njamen D, Halabalaki M, Kretzschmar G, Beyer A, Mbanya JC, Skaltsounis AL, Vollmer G.

J Steroid Biochem Mol Biol. 2010 Jun;120(4-5):184-91. doi: 10.1016/j.jsbmb.2010.04.014. Epub 2010 Apr 24.

PMID:
20420908
15.

Global analysis of estrogen receptor beta binding to breast cancer cell genome reveals an extensive interplay with estrogen receptor alpha for target gene regulation.

Grober OM, Mutarelli M, Giurato G, Ravo M, Cicatiello L, De Filippo MR, Ferraro L, Nassa G, Papa MF, Paris O, Tarallo R, Luo S, Schroth GP, Benes V, Weisz A.

BMC Genomics. 2011 Jan 14;12:36. doi: 10.1186/1471-2164-12-36.

16.

New stably transfected bioluminescent cells expressing FLAG epitope-tagged estrogen receptors to study their chromatin recruitment.

Badia E, Escande A, Balaguer P, Métivier R, Cavailles V.

BMC Biotechnol. 2009 Sep 9;9:77. doi: 10.1186/1472-6750-9-77.

17.

Evaluation of ligand selectivity using reporter cell lines stably expressing estrogen receptor alpha or beta.

Escande A, Pillon A, Servant N, Cravedi JP, Larrea F, Muhn P, Nicolas JC, Cavaillès V, Balaguer P.

Biochem Pharmacol. 2006 May 14;71(10):1459-69. Epub 2006 Mar 22.

PMID:
16554039
18.

Identification of ligands with bicyclic scaffolds provides insights into mechanisms of estrogen receptor subtype selectivity.

Hsieh RW, Rajan SS, Sharma SK, Guo Y, DeSombre ER, Mrksich M, Greene GL.

J Biol Chem. 2006 Jun 30;281(26):17909-19. Epub 2006 Apr 28.

19.

Estrogen receptor (ER) beta modulates ERalpha-mediated transcriptional activation by altering the recruitment of c-Fos and c-Jun to estrogen-responsive promoters.

Matthews J, Wihlén B, Tujague M, Wan J, Ström A, Gustafsson JA.

Mol Endocrinol. 2006 Mar;20(3):534-43. Epub 2005 Nov 17.

PMID:
16293641
20.

Mutual antagonism of estrogen receptors alpha and beta and their preferred interactions with steroid receptor coactivators in human osteoblastic cell lines.

Monroe DG, Johnsen SA, Subramaniam M, Getz BJ, Khosla S, Riggs BL, Spelsberg TC.

J Endocrinol. 2003 Mar;176(3):349-57.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk